ATP Binding Cassette Transporter C9 (ABCC9) Antibody (Biotin)

Este producto es parte de ABCC - ATP binding cassette subfamily C
Product Graph
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
ATP Binding Cassette Transporter C9 (ABCC9) Antibody (Biotin)
category
Primary Antibodies
provider
Abbexa
reference
abx315564
tested applications
ELISA

Description

ABCC9 Antibody (Biotin) is a Rabbit Polyclonal against ABCC9 conjugated to Biotin.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

CategoryPrimary Antibodies
Immunogen TargetATP Binding Cassette Transporter C9 (ABCC9)
HostRabbit
ReactivityHuman
Recommended DilutionOptimal dilutions/concentrations should be determined by the end user.
ClonalityPolyclonal
ConjugationBiotin
IsotypeIgG
Purity> 95%
PurificationPurified by Protein G.
Size 120 µg
Size 250 µg
Size 3100 µg
Size 4200 µg
Size 51 mg
FormLiquid
Tested ApplicationsELISA
Buffer0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
AvailabilityShipped within 5-10 working days.
StorageAliquot and store at -20°C. Avoid exposure to light. Avoid repeated freeze/thaw cycles.
Dry IceNo
UniProt IDO60706
Gene ID10060
NCBI AccessionNP_005682.2, NM_005691.3
OMIM239850
AliasABC37,ATFB12,CANTU,CMD1O,IDMYS,SUR2
BackgroundAntibody anti-ABCC9
StatusRUO

Descripción

ATP Binding Cassette Subfamily C Member 9 (ABCC9) encodes the sulfonylurea receptor 2 (SUR2), a key regulatory subunit of K-ATP channels found in cardiac, skeletal muscle, and smooth muscle tissues. These channels link cellular metabolism to electrical activity by sensing intracellular ATP and ADP levels, thereby regulating vascular tone and myocardial contractility. ABCC9 mutations have been associated with various conditions, including Cantu syndrome, characterized by hypertrichosis, osteochondrodysplasia, and cardiac abnormalities. The protein also plays a role in ischemic tolerance by modulating mitochondrial function and protecting tissues from damage during ischemic episodes. Pharmacologically, ABCC9 is a target for potassium channel openers, drugs that induce vasodilation and are used in the management of hypertension and angina. Its involvement in metabolic disorders and vascular diseases underscores its therapeutic significance.

Related Products

abx030224

ATP Binding Cassette Transporter C9 (ABCC9) Antibody

The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein is thought to form ATP-sensitive potassium channels in cardiac, skeletal, and vascular and non-vascular smooth muscle. Protein structure suggests a role as the drug-binding channel-modulating subunit of the extrapancreatic ATP-sensitive potassium channels. No disease has been associated with this gene thus far. Alternative splicing of this gene results in several products, two of which result from differential usage of two terminal exons and one of which results from exon deletion.

Ver Producto
abx150511

Human ATP Binding Cassette Transporter C9 (ABCC9) ELISA Kit

Human ATP Binding Cassette Transporter C9 (ABCC9) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Human ATP Binding Cassette Transporter C9 (ABCC9) concentrations in tissue homogenates, cell lysates and other biological fluids. This assay has high sensitivity and excellent specificity for detection of ATP Binding Cassette Transporter C9 (ABCC9)

Ver Producto
abx214164

ATP Binding Cassette Transporter C9 (ABCC9) Antibody

ABCC9 Antibody is a Rabbit Polyclonal against ABCC9.

Ver Producto